[{"AccountsPayableCurrent_0_FY_USD":21380000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.0325,"OperatingLeaseRightOfUseAsset_0_FY_USD":797000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":387000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":410000.0,"OperatingLeaseLiability_0_FY_USD":797000.0,"OperatingLeaseCost_4_FY_USD":400000.0,"OperatingIncomeLoss_1_FY_USD":-64601000.0,"OperatingIncomeLoss_4_FY_USD":-242482000.0,"OperatingExpenses_1_FY_USD":64601000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":3518000.0,"OperatingExpenses_4_FY_USD":242482000.0,"NetIncomeLoss_4_FY_USD":-241846000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-183917000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-5055000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":171237000.0,"LiabilitiesNoncurrent_0_FY_USD":387000.0,"LiabilitiesCurrent_0_FY_USD":76838000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":273332000.0,"Liabilities_0_FY_USD":77225000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":39000.0,"NetIncomeLoss_1_FY_USD":-64549000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_4_FY_USD":-127000.0,"OtherIncome_4_FY_USD":273000.0,"OtherIncome_1_FY_USD":0.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":79300000.0,"UnrecognizedTaxBenefits_0_FY_USD":0.0,"StockholdersEquity_0_FY_USD":196107000.0,"ShareBasedCompensation_4_FY_USD":26873000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4_FY_USD":376000.0,"Revenues_4_FY_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_4_FY_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-667310000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_FY_USD":52889000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_4_FY_USD":205164000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":851000.0,"ProfitLoss_4_FY_USD":-241846000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4_FY_USD":389274000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":1338000.0,"PreferredStockValue_0_FY_USD":null,"PreferredStockSharesOutstanding_0_FY_shares":1969797.0,"PreferredStockSharesIssued_0_FY_shares":1969797.0,"PreferredStockSharesAuthorized_0_FY_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":209000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":394120000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":436000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":836000.0,"InterestIncomeOther_4_FY_USD":363000.0,"DeferredTaxAssetsGross_0_FY_USD":211642000.0,"DeferredTaxAssetsGoodwillAndIntangibleAssets_0_FY_USD":783000.0,"DeferredTaxAssetsCharitableContributionCarryforwards_0_FY_USD":53000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-241973000.0,"CommonStockValue_0_FY_USD":2000.0,"CommonStockSharesOutstanding_0_FY_shares":17103395.0,"CommonStockSharesIssued_0_FY_shares":17103395.0,"CommonStockSharesAuthorized_0_FY_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_4_FY_USD":-17735000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":36269000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":36269000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":234077000.0,"AssetsCurrent_0_FY_USD":271684000.0,"Assets_0_FY_USD":273332000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":26873000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_4_FY_USD":26873000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":863495000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":-80000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":2455000.0,"AccruedLiabilitiesCurrent_0_FY_USD":55048000.0,"DeferredTaxAssetsLiabilitiesNet_0_FY_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":16535188.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":47864000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":23799000.0,"InterestIncomeOperating_1_FY_USD":52000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":325000.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":9826000.0,"IncreaseDecreaseInAccountsPayableTrade_4_FY_USD":20363000.0,"IncomeTaxReconciliationTaxCreditsResearch_4_FY_USD":9002000.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-19622000.0,"IncomeTaxReconciliationOtherReconcilingItems_4_FY_USD":149000.0,"IncomeTaxReconciliationNondeductibleExpenseOther_4_FY_USD":5000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-50788000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":79258000.0,"IncomeTaxExpenseBenefit_4_FY_USD":null,"IncomeTaxExaminationPenaltiesAndInterestExpense_4_FY_USD":0.0,"GeneralAndAdministrativeExpense_1_FY_USD":11712000.0,"GeneralAndAdministrativeExpense_4_FY_USD":37318000.0,"EarningsPerShareBasicAndDiluted_1_FY_USD":-3.78,"EarningsPerShareBasicAndDiluted_4_FY_USD":-14.63,"DepreciationDepletionAndAmortization_4_FY_USD":405000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":211642000.0,"DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_0_FY_USD":23000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":1857000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":24335000.0,"DeferredTaxAssetsPropertyPlantAndEquipment_0_FY_USD":80000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_FY_shares":17074543.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20220224"}]